Paul Tudor Jones's WVE Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 97,900 shares of Wave Life Sciences Ltd. (WVE) worth $709,775, representing 0.00% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in WVE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 97,900 shares. Largest reduction occurred in Q2 2025, reducing 76,926 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +97,900 | New Buy | 97,900 | $7.25 |
| Q2 2025 | -76,926 | Sold Out | 0 | $0.00 |
| Q1 2025 | +76,926 | New Buy | 76,926 | $8.08 |
| Q4 2024 | -15,202 | Sold Out | 0 | $0.00 |
| Q3 2024 | +15,202 | New Buy | 15,202 | $8.20 |
| Q1 2024 | -36,580 | Sold Out | 0 | $0.00 |
| Q4 2023 | +36,580 | New Buy | 36,580 | $5.05 |
| Q3 2023 | -42,217 | Sold Out | 0 | $0.00 |
| Q1 2023 | -382 | Reduce 0.90% | 42,217 | $0.00 |
| Q4 2022 | -553 | Reduce 1.28% | 42,599 | $0.01 |
| Q1 2022 | +13,857 | Add 47.30% | 43,152 | $1.99 |
| Q4 2021 | +1,058 | Add 3.75% | 29,295 | $3.14 |
| Q3 2021 | +28,237 | New Buy | 28,237 | $4.89 |
| Q2 2021 | -46,025 | Sold Out | 0 | $0.00 |
| Q1 2021 | +46,025 | New Buy | 46,025 | $5.61 |
| Q4 2020 | -53,967 | Sold Out | 0 | $0.00 |
| Q3 2020 | +53,967 | New Buy | 53,967 | $8.49 |
| Q1 2019 | -9,840 | Sold Out | 0 | $0.00 |
| Q4 2018 | -3,558 | Reduce 26.56% | 9,840 | $42.07 |
| Q3 2018 | +13,398 | New Buy | 13,398 | $50.01 |
Paul Tudor Jones's Wave Life Sciences Investment FAQs
Paul Tudor Jones first purchased Wave Life Sciences Ltd. (WVE) in Q3 2018, acquiring 13,398 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Wave Life Sciences Ltd. (WVE) for 23 quarters since Q3 2018.
Paul Tudor Jones's largest addition to Wave Life Sciences Ltd. (WVE) was in Q1 2026, adding 97,900 shares worth $709,775.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 97,900 shares of Wave Life Sciences Ltd. (WVE), valued at approximately $709,775.
As of the Q1 2026 filing, Wave Life Sciences Ltd. (WVE) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Wave Life Sciences Ltd. (WVE) was 97,900 shares, as reported at the end of Q1 2026.